Octadec-9-enyl propanoate

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: Octadec-9-enyl propanoate
• 英文别名: octadec-9-enyl propanoate
• 化学式: C₂₁H₄₀O₂
• 分子量: 324.5
• InChiKey: MEJZTQBVYODKTI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  8.5
• 重原子数：
  23
• 可旋转键数：
  18
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• PIGMENT COMPOSITION, DISPERSION CONTAINING THE SAME, AND COLOR RESIST FOR COLOR FILTER
  申请人：DAINIPPON INK AND CHEMICALS, INC.

  公开号：EP1077234A1

  公开（公告）日：2001-02-21

  A pigment composition in which an ester compound ordinarily used as a solvent and in other applications, such as butyl acetate or oleyl acetate, is used as a flowability improver for a pigment dispersion and which comprises a pigment and the ester compound as essential ingredients, and a pigment dispersion obtained by dispersing the pigment composition in a solvent, etc. The dispersion is significantly improved in pigment dispersibility and flowability. When the pigment composition or pigment dispersion is used in producing a color filter, a homogeneous film having high contrast can be obtained.

  一种颜料组合物，其中通常用作溶剂和其他用途的酯类化合物（如醋酸丁酯或醋酸油酯）被用作颜料分散体的流动性改进剂，该颜料组合物包括作为主要成分的颜料和酯类化合物，以及通过将颜料组合物分散在溶剂等中而得到的颜料分散体。该分散体在颜料分散性和流动性方面都有明显改善。当颜料组合物或颜料分散体用于生产彩色滤光片时，可获得具有高对比度的均匀薄膜。
• A MICROEMULSION PREPARATION OF HIGH CONCENTRATION PROPOFOL FOR ANESTHETIC USES
  申请人：BIOAVAILABILITY, INC.

  公开号：EP1713444A1

  公开（公告）日：2006-10-25
• HIGH CONCENTRATION SELF-MICROEMULSIFYING COENZYME Q10 PREPARATIONS FOR NUTRITIONAL USE
  申请人：BIOAVAILABILITY, INC.

  公开号：EP1811977A2

  公开（公告）日：2007-08-01
• Microemulsion preparation of high concentration propofol for anesthetic uses
  申请人：Harris B. Steve

  公开号：US20070141090A1

  公开（公告）日：2007-06-21

  The invention provides a method and a composition for enhancing the dissolution and bioavailable properties of propofol (2,6 diisopropyl phenol) for use as an intravenously administered anesthetic in mammals. The method produces a self-microemulsifyable emulsion base composition that is utilized in the production of a water-based microemulsiori preparation. In a preferred two (2) component base composition, the base composition consists of: a surfactant, containing polyethylene glycol; and liquid propofol. The microemulsion is prepared by mixing the base composition with a carrier liquid, which results in the formation of a microemulsion containing concentrations of propofol of up to about 4% by weight of propofol to the volume of the microemulsion. In a four (4) component base composition, the base composition consists of: a surfactant, containing polyethylene glycol; liquid propofol; a water-immiscible solvent; and ethanol. The microemulsion is prepared by mixing the base composition with a carrier liquid, which results in the formation of a microemulsion containing concentrations of propofol of up to about 10% by weight of propofol to the volume of the microemulsion.
• High Concentration Self-Microemulsifying Coenzyme Q10 Preparations For Nutritional Use
  申请人：Harris Steven B.

  公开号：US20090060891A1

  公开（公告）日：2009-03-05

  A method and composition are presented for enhancing the dissolution and bioavailable properties of CoQ10 nutritional supplements and/or therapeutic agents for a human being and other mammals. The method includes preparing an anhydrous self-microemulsifying base composition by combining: CoQ10, a water-immiscible, and a non-ionic surfactant, containing polyethylene glycol. For an orally administered CoQ10 nutritional supplement in a capsule formulation, a unit dosage from the composition is added to a dissolvable capsule, preferably a soft gelatin capsule, in order to form the nutritional supplement. When a capsule containing the self-microemulsifying composition enters the digestive tract, the temperature of the body's digestive juices warms the composition, causing any of the CoQ10 that may have re-crystallized out of the composition to become re-dissolved into the composition before the capsule dissolves. The re-dissolution of CoQ10 is bioavailable when the capsule dissolves. Upon dissolution of the capsule, the self-microemulsifying composition comes into contact with the digestive juices and naturally forms micellar-type bioavaible microemulsions, consisting of micelles containing CoQ10. In addition to the capsule formulation, the invention includes parenteral, liquid, topical and ophthalmic formulations.